Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noffisat O Oki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Toxicology|April 25, 2016
An integrative data mining approach to identifying adverse outcome pathway signaturesNoffisat O Oki, Stephen W Edwards
Pharmacogenomics|February 25, 2012
Are plasma level and CYP genotypes predictors of liver injury in an Ethiopian population?Noffisat O Oki, Alison A Motsinger-Reif
Frontiers in Genetics|February 4, 2012
Multifactor dimensionality reduction as a filter-based approach for genome wide association studiesNoffisat O Oki, Alison A Motsinger-Reif
Regulatory Toxicology and Pharmacology : RTP|April 7, 2020
A semi-automated workflow for adverse outcome pathway hypothesis generation: The use case of non-genotoxic induced hepatocellular carcinomaTatyana Y Doktorova, Noffisat O Oki, Tomaž Mohorič, et al.
Current Environmental Health Reports|January 27, 2016
Accelerating Adverse Outcome Pathway Development Using Publicly Available Data SourcesNoffisat O Oki, Mark D Nelms, Shannon M Bell, et al.
BMC Research Notes|February 2, 2011
Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association studyNoffisat O Oki, Alison A Motsinger-Reif, Paulo Rz Antas, et al.
BMC Medical Genetics|March 4, 2010
Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosisAlison A Motsinger-Reif, Paulo R Z Antas, Noffisat O Oki, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 10, 2018
Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver modelsNoffisat O Oki, Lucian Farcal, Ahmed Abdelaziz, et al.
Frontiers in Pharmacology|July 6, 2016
Pharmacometabolomic Assessment of Metformin in Non-diabetic, African AmericansDaniel M Rotroff, Noffisat O Oki, Xiaomin Liang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Toxicology|April 25, 2016
An integrative data mining approach to identifying adverse outcome pathway signaturesNoffisat O Oki, Stephen W Edwards
Pharmacogenomics|February 25, 2012
Are plasma level and CYP genotypes predictors of liver injury in an Ethiopian population?Noffisat O Oki, Alison A Motsinger-Reif
Frontiers in Genetics|February 4, 2012
Multifactor dimensionality reduction as a filter-based approach for genome wide association studiesNoffisat O Oki, Alison A Motsinger-Reif
Regulatory Toxicology and Pharmacology : RTP|April 7, 2020
A semi-automated workflow for adverse outcome pathway hypothesis generation: The use case of non-genotoxic induced hepatocellular carcinomaTatyana Y Doktorova, Noffisat O Oki, Tomaž Mohorič, et al.
Current Environmental Health Reports|January 27, 2016
Accelerating Adverse Outcome Pathway Development Using Publicly Available Data SourcesNoffisat O Oki, Mark D Nelms, Shannon M Bell, et al.
BMC Research Notes|February 2, 2011
Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association studyNoffisat O Oki, Alison A Motsinger-Reif, Paulo Rz Antas, et al.
BMC Medical Genetics|March 4, 2010
Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosisAlison A Motsinger-Reif, Paulo R Z Antas, Noffisat O Oki, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 10, 2018
Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver modelsNoffisat O Oki, Lucian Farcal, Ahmed Abdelaziz, et al.
Frontiers in Pharmacology|July 6, 2016
Pharmacometabolomic Assessment of Metformin in Non-diabetic, African AmericansDaniel M Rotroff, Noffisat O Oki, Xiaomin Liang, et al.
Pageof 1